CADE approves pharma merger with restrictions

Brazil’s antitrust tribunal, CADE, has approved French pharmaceutical company Sanofi-Aventis’ purchase of Brazilian generics group Medley, on the condition that they divest three drugs.

Unlock unlimited access to all Latin Lawyer content